GENERATION BIO CO. - COMMON STOCK, $0.0001 PAR VALUE (GBIO)

CUSIP: 37148K100

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
-6,144,966
Put/Call ratio
1%
SEC-reported price per share
$0.40
Number of holders
80
Value change
-$4,690,760
Number of buys
24
Open additional details 1 more signal available
Number of sells
45
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
67,017,829

Security key

37148K100

Report period

Q1 2025

Institutions

80

Top holders

10

Ownership snapshot

Top reported holders of GBIO - GENERATION BIO CO. - COMMON STOCK, $0.0001 PAR VALUE (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ATLAS VENTURE ASSOCIATES ...
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
0/15
Latest evidence
10 Jan 2025
3/4/5 13F Highest disclosed value: $9,836,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

PRICE T ROWE ASSOCIATES INC /MD/ has the largest disclosed position value at $9.84M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens PRICE T ROWE ASSOCIATES INC /MD/'s linked filing trail.
Disclosed position value Top 5
ATLAS VENTURE ASSOCIATES X, L.P. $1.2K
PRICE T ROWE ASSOCIATES INC /MD/ $9.84M
Atlas Venture Life Science Adviso... $8.78M
BlackRock, Inc. $3.67M
BANK OF AMERICA CORP /DE/ $3.18M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ATLAS VENTURE ASSOCIATES X, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$1,161
608 shares
— 27 Sep 2021
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$9,836,000
9,279,059 shares
— 31 Dec 2024
Atlas Venture Life Science Advisors, LLC
13F
Company
13F
—
denominator unverified
$8,776,253
8,279,484 shares
— 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$3,666,611
3,459,065 shares
— 31 Dec 2024
BANK OF AMERICA CORP /DE/
13F
Company
13F
—
denominator unverified
$3,177,603
2,997,739 shares
— 31 Dec 2024
Siren, L.L.C.
13F
Individual
13F
—
denominator unverified
$3,161,697
2,982,733 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
80
Shares
47,705,137
Rows available
80
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2026 Across Filers

Q1 2026 holders
1
Q1 2025 holders
80
Holder diff
79
Investor Q1 2026 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2026 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .